Heterogeneous Pancreas: Causes, Functional Impact, and Clinical Management

Definition

Heterogeneous pancreas refers to structural or functional variation across pancreatic regions (head, body, tail), visible on imaging or histology.

Etiologies

• Developmental anomalies: Aberrant branching/fusion → pancreas divisum, annular pancreas, ectopic tissue.
• Anatomical variants: Ductal branching patterns (e.g., common channel vs. separate drainage).
• Functional zoning: Head = predominantly exocrine (digestive enzymes); body/tail = predominantly endocrine (islets: insulin, glucagon).
• Pathology:
  • Chronic pancreatitis: Fibrosis, atrophy, calcifications—patchy distribution.
  • Neoplasms: Ductal adenocarcinoma, neuroendocrine tumors—focal disruption.
  • Fatty replacement: Metabolic syndrome, aging.
  • Autoimmune pancreatitis: Diffuse or focal enlargement.

Functional Consequences

• Exocrine insufficiency: Maldigestion, steatorrhea, fat-soluble vitamin deficiency.
• Endocrine dysfunction: Impaired glucose regulation → diabetes (type 3c pancreatogenic).

Diagnostic Evaluation

• Imaging: CT, MRI, EUS (endoscopic ultrasound) for morphology.
• Function: Fecal elastase-1 (exocrine); fasting glucose, HbA1c, C-peptide, mixed-meal tolerance (endocrine).

Management

• Pancreatic enzyme replacement therapy (PERT) for exocrine insufficiency.
• Insulin or GLP-1 agonists for diabetes; avoid sulfonylureas if possible.
• Surgery for complications (pseudocyst, obstruction, neoplasm).
• Surveillance for high-risk variants (e.g., IPMN, PRSS1 mutations).